Telehealth company Ro has a new spokesperson for its booming GLP-1 business: Serena Williams, the 23-time Grand Slam champion ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

Serena Williams has joined the growing number of people turning to GLP-1 medications as a weight-loss solution. The tennis ...

Serena Williams broke her silence about her weight loss journey, revealing she used medication to help her lose 31 pounds.

The tennis champion says she was skeptical at first, and now wants to help lessen the stigma around weight loss medication.